Willow Biosciences Inc. (WLLW.TO)
CAD 0.06
(-20.0%)
CAD 0.06
(-20.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.02 Million CAD | 12.05% |
| 2022 | -14.81 Million CAD | -140.21% |
| 2021 | -6.16 Million CAD | 81.85% |
| 2020 | -33.98 Million CAD | 23.74% |
| 2019 | -44.56 Million CAD | -2609.93% |
| 2018 | -1.64 Million CAD | 11.45% |
| 2017 | -1.85 Million CAD | 20.28% |
| 2016 | -2.32 Million CAD | -77.77% |
| 2015 | -1.31 Million CAD | -51.44% |
| 2014 | -865.37 Thousand CAD | 37.62% |
| 2013 | -1.38 Million CAD | 22.96% |
| 2012 | -1.8 Million CAD | -27.06% |
| 2011 | -1.41 Million CAD | 55.95% |
| 2010 | -3.21 Million CAD | -5.22% |
| 2009 | -3.05 Million CAD | -165.38% |
| 2008 | -1.15 Million CAD | 30.28% |
| 2007 | -1.65 Million CAD | -308.58% |
| 2006 | -404.4 Thousand CAD | -3.6% |
| 2005 | -390.35 Thousand CAD | -79.23% |
| 2004 | -217.79 Thousand CAD | 28.85% |
| 2003 | -306.12 Thousand CAD | -336.04% |
| 2002 | -70.2 Thousand CAD | 57.01% |
| 2001 | -163.3 Thousand CAD | 10.84% |
| 2000 | -183.15 Thousand CAD | -60.05% |
| 1999 | -114.43 Thousand CAD | 43.38% |
| 1998 | -202.12 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.35 Million CAD | 2.72% |
| 2024 Q2 | -1.68 Million CAD | 28.46% |
| 2023 Q2 | -3.6 Million CAD | 23.12% |
| 2023 Q1 | -4.68 Million CAD | 0.42% |
| 2023 Q4 | -2.42 Million CAD | -8.65% |
| 2023 Q3 | -2.23 Million CAD | 38.1% |
| 2023 FY | -13.02 Million CAD | 12.05% |
| 2022 FY | -14.81 Million CAD | -140.21% |
| 2022 Q2 | -443 Thousand CAD | -153.31% |
| 2022 Q3 | -3.98 Million CAD | -799.77% |
| 2022 Q4 | -4.7 Million CAD | -18.11% |
| 2022 Q1 | 831 Thousand CAD | 115.99% |
| 2021 Q3 | 3.83 Million CAD | -41.15% |
| 2021 FY | -6.16 Million CAD | 81.85% |
| 2021 Q1 | -11.3 Million CAD | 23.95% |
| 2021 Q2 | 6.52 Million CAD | 157.7% |
| 2021 Q4 | -5.19 Million CAD | -235.37% |
| 2020 FY | -33.98 Million CAD | 23.74% |
| 2020 Q1 | -1.41 Million CAD | 54.29% |
| 2020 Q4 | -14.86 Million CAD | -95.75% |
| 2020 Q2 | -10.06 Million CAD | -611.27% |
| 2020 Q3 | -7.59 Million CAD | 24.57% |
| 2019 FY | -44.56 Million CAD | -2609.93% |
| 2019 Q3 | -1.09 Million CAD | 97.24% |
| 2019 Q2 | -39.84 Million CAD | -6432.84% |
| 2019 Q1 | -609.9 Thousand CAD | -162.1% |
| 2019 Q4 | -3.09 Million CAD | -181.71% |
| 2018 FY | -1.64 Million CAD | 11.45% |
| 2018 Q4 | -232.69 Thousand CAD | 24.35% |
| 2018 Q3 | -307.61 Thousand CAD | 58.52% |
| 2018 Q2 | -741.52 Thousand CAD | -4.15% |
| 2018 Q1 | -711.96 Thousand CAD | -325.31% |
| 2017 Q3 | -236.3 Thousand CAD | 85.5% |
| 2017 Q4 | -167.4 Thousand CAD | 29.16% |
| 2017 FY | -1.85 Million CAD | 20.28% |
| 2017 Q1 | -183.73 Thousand CAD | -18.0% |
| 2017 Q2 | -1.62 Million CAD | -786.9% |
| 2016 Q2 | -805.13 Thousand CAD | -480.15% |
| 2016 Q3 | -360.76 Thousand CAD | 55.19% |
| 2016 Q4 | -155.7 Thousand CAD | 56.84% |
| 2016 FY | -2.32 Million CAD | -77.77% |
| 2016 Q1 | -138.78 Thousand CAD | 32.7% |
| 2015 Q4 | -206.21 Thousand CAD | -28.56% |
| 2015 Q3 | -160.4 Thousand CAD | 22.07% |
| 2015 Q2 | -205.85 Thousand CAD | -18.75% |
| 2015 Q1 | -173.34 Thousand CAD | 2.12% |
| 2015 FY | -1.31 Million CAD | -51.44% |
| 2014 Q2 | -658.67 Thousand CAD | -200.46% |
| 2014 FY | -865.37 Thousand CAD | 37.62% |
| 2014 Q1 | -219.22 Thousand CAD | 23.09% |
| 2014 Q4 | -177.1 Thousand CAD | 42.7% |
| 2014 Q3 | -309.07 Thousand CAD | 53.08% |
| 2013 Q4 | -285.03 Thousand CAD | -27.12% |
| 2013 Q2 | -1.31 Million CAD | -573.14% |
| 2013 Q3 | -224.23 Thousand CAD | 82.99% |
| 2013 Q1 | -195.81 Thousand CAD | -24.27% |
| 2013 FY | -1.38 Million CAD | 22.96% |
| 2012 Q4 | -157.57 Thousand CAD | -22.12% |
| 2012 FY | -1.8 Million CAD | -27.06% |
| 2012 Q3 | -129.03 Thousand CAD | 32.09% |
| 2012 Q2 | -190.01 Thousand CAD | 9.52% |
| 2012 Q1 | -209.99 Thousand CAD | 67.47% |
| 2011 Q3 | -371.62 Thousand CAD | 74.79% |
| 2011 FY | -1.41 Million CAD | 55.95% |
| 2011 Q4 | -645.47 Thousand CAD | -73.69% |
| 2011 Q1 | -178.6 Thousand CAD | 85.91% |
| 2011 Q2 | -1.47 Million CAD | -725.25% |
| 2010 Q3 | -296.36 Thousand CAD | 78.01% |
| 2010 FY | -3.21 Million CAD | -5.22% |
| 2010 Q1 | -237.53 Thousand CAD | 79.53% |
| 2010 Q2 | -1.34 Million CAD | -467.29% |
| 2010 Q4 | -1.26 Million CAD | -327.83% |
| 2009 Q2 | -60.36 Thousand CAD | 80.88% |
| 2009 Q4 | -1.16 Million CAD | -272.04% |
| 2009 Q1 | -315.76 Thousand CAD | 27.81% |
| 2009 FY | -3.05 Million CAD | -165.38% |
| 2009 Q3 | -311.88 Thousand CAD | -416.69% |
| 2008 FY | -1.15 Million CAD | 30.28% |
| 2008 Q1 | -273.95 Thousand CAD | 28.61% |
| 2008 Q4 | -437.39 Thousand CAD | -29.23% |
| 2008 Q3 | -338.46 Thousand CAD | 57.24% |
| 2008 Q2 | -791.6 Thousand CAD | -188.96% |
| 2007 Q1 | -56.37 Thousand CAD | 26.8% |
| 2007 FY | -1.65 Million CAD | -308.58% |
| 2007 Q4 | -383.71 Thousand CAD | -76.45% |
| 2007 Q3 | -217.46 Thousand CAD | -13.96% |
| 2007 Q2 | -190.82 Thousand CAD | -238.53% |
| 2006 Q4 | -77.01 Thousand CAD | 3.97% |
| 2006 FY | -404.4 Thousand CAD | -3.6% |
| 2006 Q1 | -65.42 Thousand CAD | -276.37% |
| 2006 Q2 | -280.99 Thousand CAD | -329.5% |
| 2006 Q3 | -80.19 Thousand CAD | 71.46% |
| 2005 FY | -390.35 Thousand CAD | -79.23% |
| 2005 Q1 | 379 Thousand CAD | 673.79% |
| 2005 Q2 | -495.47 Thousand CAD | -230.73% |
| 2005 Q3 | -26.54 Thousand CAD | 94.64% |
| 2005 Q4 | -17.38 Thousand CAD | 34.52% |
| 2004 Q3 | -35.27 Thousand CAD | 86.39% |
| 2004 Q4 | -66.05 Thousand CAD | -87.28% |
| 2004 Q2 | -259.19 Thousand CAD | -1562.02% |
| 2004 Q1 | -15.59 Thousand CAD | -2.48% |
| 2004 FY | -217.79 Thousand CAD | 28.85% |
| 2003 FY | -306.12 Thousand CAD | -336.04% |
| 2003 Q4 | -15.21 Thousand CAD | 5.59% |
| 2003 Q3 | -16.11 Thousand CAD | 16.65% |
| 2003 Q2 | -19.33 Thousand CAD | 14.06% |
| 2003 Q1 | -22.5 Thousand CAD | 12.63% |
| 2002 Q1 | -33.18 Thousand CAD | 21.5% |
| 2002 FY | -70.2 Thousand CAD | 57.01% |
| 2002 Q2 | -23.69 Thousand CAD | 28.6% |
| 2002 Q4 | -25.75 Thousand CAD | -887.16% |
| 2002 Q3 | -2609.00 CAD | 88.99% |
| 2001 Q2 | -65.14 Thousand CAD | -23.24% |
| 2001 Q3 | -64.16 Thousand CAD | 1.52% |
| 2001 FY | -163.3 Thousand CAD | 10.84% |
| 2001 Q4 | -42.27 Thousand CAD | 34.11% |
| 2001 Q1 | -52.86 Thousand CAD | -54.76% |
| 2000 Q4 | -34.15 Thousand CAD | -10.24% |
| 2000 FY | -183.15 Thousand CAD | -60.05% |
| 2000 Q3 | -30.98 Thousand CAD | 0.0% |
| 1999 FY | -114.43 Thousand CAD | 43.38% |
| 1998 FY | -202.12 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aurora Cannabis Inc. | -69.32 Million CAD | 81.206% |
| Avicanna Inc. | -8.74 Million CAD | -49.022% |
| Avant Brands Inc. | -5.07 Million CAD | -156.982% |
| Cardiol Therapeutics Inc. | -28.12 Million CAD | 53.68% |
| Crescita Therapeutics Inc. | -1.98 Million CAD | -556.042% |
| Knight Therapeutics Inc. | -16.83 Million CAD | 22.608% |
| MediPharm Labs Corp. | -13.08 Million CAD | 0.413% |
| OrganiGram Holdings Inc. | -229.47 Million CAD | 94.322% |
| Canopy Growth Corporation | -657.26 Million CAD | 98.018% |
| Auxly Cannabis Group Inc. | -44.51 Million CAD | 70.729% |